Journal
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
Volume 29, Issue 3, Pages 356-373Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2015.08.002
Keywords
Musculoskeletal; Productivity; Employment; Sickness absence; Work disability; Early intervention; European Union
Categories
Funding
- Abbvie for the 'Fit for Work' initiative
Ask authors/readers for more resources
Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, 'presenteeism' and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available